New Parkinson's disease drug target revealed through study of fatty acids

December 04, 2018

The human brain is rich in lipids. Investigators studying Parkinson's disease (PD) have become increasingly interested in lipids since both molecular and genetic studies have pointed to the disruption of the balance of the brain's lipids as a potentially critical contributor to this disease. Beginning in yeast and moving through various model organisms and human cells, a new study led by investigators from Brigham and Women's Hospital and Harvard Medical School has provided insights into the role of fatty acids and suggests that inhibiting a specific enzyme can protect against neurotoxicity. Their findings, which point to a novel therapeutic approach that could be developed to treat PD and some forms of Alzheimer's disease, are published in Molecular Cell.

"People have been aware for many years of some connection between Parkinson's disease and the brain's lipids," said lead author Saranna Fanning, PhD, of the Ann Romney Center for Neurologic Diseases at the Brigham and Harvard Medical School. "Through this collaborative effort, beginning with yeast models in the Lindquist lab and in the Selkoe and Dettmer labs leveraging rat cortical neurons and human cortical neurons, we've identified a pathway and a therapeutic target that no one has pursued before."

Fanning's work began in the lab of the Whitehead Institute's Susan Lindquist, PhD, who passed away in 2016. She performed unbiased lipidomic profiling, measuring lipids and fatty acid changes in yeast that had been engineered to produce α-synuclein, a protein that forms the hallmark Lewy body clumps of PD. An increase was identified in the constituents of the neutral lipids pathway, including a monounsaturated fatty acid known as oleic acid. This finding was then replicated in rodent and human neuronal models, including patient cell lines, by Fanning and colleagues in the labs of co-senior authors Dennis Selkoe, MD, and Ulf Dettmer, PhD, at the Brigham. Additional experiments were carried out in the roundworm C. elegans, another classic model organism.

"It was fascinating to see how excess αS had such consistent effects on the neutral lipid pathway across model organisms, from simple baker's yeast and cultured rodent neurons to cells derived from PD patients that carry extra copies of α-synuclein in their genome. All our models clearly pointed at oleic acid as a mediator of α-synuclein toxicity," said Dettmer.

The team also measured signs of neurotoxicity in their models, looking for ways to target fatty acids or the pathways involved in their generation that would offer protection from PD. The researchers found that suppressing an enzyme known as stearoyl-CoA-desaturase (SCD), which helps generate oleic acid and other monounsaturated fatty acids, was protective, suggesting that SCD may be a promising therapeutic target.

While not currently used in the clinic, multiple inhibitors of SCD exist today and are used in research labs. Additional follow-up studies will be required to determine how well such testing begins in humans.

"The identification of SCD as an enzyme which contributes to α-synuclein-mediated lipid changes and neurotoxicity presents a unique opportunity for small-molecule therapies to inhibit the enzyme in models of PD and, ultimately, in human diseases," said Selkoe.
Funding for this work was provided by the JPB Foundation, a fellowship from the Jane Coffin Childs Memorial Fund for medical research the National Institutes of Health (grants NS065743, GM102155, NS103123, NS099328, NS083845), the Austrian Science Fund FWF, and DK Molecular Enzymology Project W901 NAWI Graz.

Paper cited: Fanning, S et al. "Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment" Molecular Cell DOI: 10.1016/j.molcel.2018.11.028

Image Caption: Lead author Dr. Saranna Fanning (top row, middle), senior authors Dr. Ulf Dettmer (bottom row, right) and Dr. Dennis Selkoe (bottom row, left) and colleagues have uncovered a potential therapeutic target for Parkinson's disease. Increased lipid droplets (green fluorescence) in yeast (top row, left), rat (bottom row, middle) and human cortical neurons (top row, right) indicating activation of the neutral lipids pathway upon alpha-synuclein expression. Inhibition of SCD upstream of this pathway represents a novel PD therapeutic approach.

Brigham and Women's Hospital

Related Fatty Acids Articles from Brightsurf:

A new tool to create chemical complexity from fatty acids
A new catalyst design enables unprecedented control over the modification of fatty acid derivatives that opens the door to creating useful substances in a green and efficient manner.

The ova of obese women have lower levels of omega-3 fatty acids
A study conducted by researchers from the UPV/EHU, Cruces Hospital, the IVI Clinic Bilbao and Biocruces Bizkaia shows that the oocytes of obese or overweight women have a different composition of fatty acids.

Scientists use light to convert fatty acids into alkanes
Researchers led by Prof. WANG Feng at the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences have reported that photocatalytic decarboxylation is an efficient alternate pathway for converting biomass-derived fatty acids into alkanes under mild conditions of ambient temperature and pressure.

Microbes from humics lakes produced omega-3 fatty acids from micropla
The environmental fate of microplastics has been difficult to trace.

Efficiently producing fatty acids and biofuels from glucose
Researchers have presented a new strategy for efficiently producing fatty acids and biofuels that can transform glucose and oleaginous microorganisms into microbial diesel fuel, with one-step direct fermentative production.

Omega-3 fatty acids tied to fewer childhood asthma symptoms
A six-month study of children from Baltimore City by Johns Hopkins Medicine researchers has added to evidence that having more omega-3 fatty acids in the diet results in fewer asthma symptoms triggered by indoor air pollution.

Could omega-3 fatty acids help prevent miscarriages?
A new study in mice reveals that omega-3s, a type of fat found in fish oil, reduces fetal and neonatal deaths, suggesting they could prevent some miscarriages in women.

Researchers reveal prostate tumors 'fed' by fatty acids
An international multidisciplinary study initiated by Melbourne scientists has shown a link between prostate cancer and the uptake of fatty acids by cancer cells.

A hidden route for fatty acids can make cancers resistant to therapy
Researchers from the lab of Prof. Sarah-Maria Fendt at the VIB-KU Leuven Center for Cancer Biology now demonstrate that certain tumor cells use an alternative -- previously unexplored -- pathway to produce fatty acids.

Sunscreen and cosmetics compound may harm coral by altering fatty acids
Although sunscreen is critical for preventing sunburns and skin cancer, some of its ingredients are not so beneficial to ocean-dwelling creatures.

Read More: Fatty Acids News and Fatty Acids Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to